These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34554235)

  • 21. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
    Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H
    Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
    Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY
    J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters.
    Field CJ; Heinly TA; Patel DR; Sim DG; Luley E; Gupta SL; Vanderford TH; Wrammert J; Sutton TC
    Emerg Microbes Infect; 2022 Dec; 11(1):1103-1114. PubMed ID: 35333692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.
    Osterrieder N; Bertzbach LD; Dietert K; Abdelgawad A; Vladimirova D; Kunec D; Hoffmann D; Beer M; Gruber AD; Trimpert J
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32698441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
    Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
    Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular tropism of SARS-CoV-2 in the respiratory tract of Syrian hamsters and B6.Cg-Tg(K18-ACE2)2Prlmn/J transgenic mice.
    Yen HL; Valkenburg S; Sia SF; Choy KT; Peiris JSM; Wong KHM; Crossland N; Douam F; Nicholls JM
    Vet Pathol; 2022 Jul; 59(4):639-647. PubMed ID: 34467820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
    Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
    Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal Mucosa Exploited by SARS-CoV-2 for Replicating and Shedding during Reinfection.
    Li H; Zhao X; Li J; Zheng H; Zhao Y; Yang J; Zhou J; Yang F; Chen Y; Zuo Y; Lai Q; Long H; Li Y; Jin W; Shi H; Liu L
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19.
    Zumbrun EE; Kaku CI; Dillinger L; Zak SE; Kuehne AI; Bakken RR; Koehler JW; Delp KL; Stefan CP; Kumar R; Kugelman JR; Moreau AM; Zeng X; Dye JM; Herbert AS; Narayan K; Walker LM
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0135322. PubMed ID: 36519929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
    Uraki R; Kiso M; Imai M; Yamayoshi S; Ito M; Fujisaki S; Takashita E; Ujie M; Furusawa Y; Yasuhara A; Iwatsuki-Horimoto K; Sakai-Tagawa Y; Watanabe S; Hasegawa H; Kawaoka Y
    Nat Microbiol; 2022 Aug; 7(8):1252-1258. PubMed ID: 35705860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
    Choudhary S; Kanevsky I; Yildiz S; Sellers RS; Swanson KA; Franks T; Rathnasinghe R; Munoz-Moreno R; Jangra S; Gonzalez O; Meade P; Coskran T; Qian J; Lanz TA; Johnson JG; Tierney CA; Smith JD; Tompkins K; Illenberger A; Corts P; Ciolino T; Dormitzer PR; Dick EJ; Shivanna V; Hall-Ursone S; Cole J; Kaushal D; Fontenot JA; Martinez-Romero C; McMahon M; Krammer F; Schotsaert M; García-Sastre A
    Toxicol Pathol; 2022 Apr; 50(3):280-293. PubMed ID: 35128980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
    Imai M; Halfmann PJ; Yamayoshi S; Iwatsuki-Horimoto K; Chiba S; Watanabe T; Nakajima N; Ito M; Kuroda M; Kiso M; Maemura T; Takahashi K; Loeber S; Hatta M; Koga M; Nagai H; Yamamoto S; Saito M; Adachi E; Akasaka O; Nakamura M; Nakachi I; Ogura T; Baba R; Fujita K; Ochi J; Mitamura K; Kato H; Nakajima H; Yagi K; Hattori SI; Maeda K; Suzuki T; Miyazato Y; Valdez R; Gherasim C; Furusawa Y; Okuda M; Ujie M; Lopes TJS; Yasuhara A; Ueki H; Sakai-Tagawa Y; Eisfeld AJ; Baczenas JJ; Baker DA; O'Connor SL; O'Connor DH; Fukushi S; Fujimoto T; Kuroda Y; Gordon A; Maeda K; Ohmagari N; Sugaya N; Yotsuyanagi H; Mitsuya H; Suzuki T; Kawaoka Y
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34140350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
    Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL
    Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
    Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters.
    Lamirande EW; DeDiego ML; Roberts A; Jackson JP; Alvarez E; Sheahan T; Shieh WJ; Zaki SR; Baric R; Enjuanes L; Subbarao K
    J Virol; 2008 Aug; 82(15):7721-4. PubMed ID: 18463152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum.
    Handley A; Ryan KA; Davies ER; Bewley KR; Carnell OT; Challis A; Coombes NS; Fotheringham SA; Gooch KE; Charlton M; Harris DJ; Kennard C; Ngabo D; Weldon TM; Salguero FJ; Funnell SGP; Hall Y
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.
    Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS
    Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model.
    Johnson S; Martinez CI; Tedjakusuma SN; Peinovich N; Dora EG; Birch SM; Kajon AE; Werts AD; Tucker SN
    J Infect Dis; 2022 Jan; 225(1):34-41. PubMed ID: 34758086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.